A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL

Condition:   B-cell Non Hodgkin Lymphoma Intervention:   Biological: GC022F Sponsors:   Hebei Yanda Ludaopei Hospital;   Gracell Biotechnology Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials